Quest PharmaTech Inc

Type: Company
Name: Quest PharmaTech Inc
First reported Mar 26 2014 - Updated Mar 26 2014 - 1 reports

TSX Biotech Stocks to Watch; Innovative Ovarian Cancer Treatments

(Investorideas.com Newswire) Investorideas.com, a global news source for leading sectors including biotech and pharma issues a sector snapshot of TSX biotech stocks targeting ovarian cancer as part of their product pipeline. Stocks mentioned include Quest ... [Published InvestorIdeas.com - Mar 26 2014]
First reported Mar 19 2014 - Updated Mar 19 2014 - 1 reports

Quest PharmaTech Announces Third Combinatorial Immunotherapy Clinical Trial for Oregovomab with a TLR3 agonist, Hiltonol®

TSX Venture: QPTEDMONTON, Jan. 29, 2014 /CNW/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, announced today that is has entered into a license ... [Published Alberta Venture - Mar 19 2014]
First reported Mar 13 2014 - Updated Mar 13 2014 - 1 reports

Oncothyreon Reports Full Year and Fourth Quarter 2013 Financial Results

TSX Venture: QPTEDMONTON , Nov. 7, 2013 /PRNewswire/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, announces the presentation of a late-breaking ... [Published Barchart - Mar 13 2014]
First reported Jan 29 2014 - Updated Jan 29 2014 - 1 reports

Quest Pharmatech, Oncovir to combine tech for study

Quest Pharmatech Inc. has entered into a licence agreement with Oncovir Inc. (based in Washington) to evaluate the clinical utility of combining Quest's antibody immunotherapy technology with Oncovir's immune activator, Hiltonol, in a 20-patient ovarian ... [Published Stockwatch - Jan 29 2014]
First reported Jan 23 2014 - Updated Jan 23 2014 - 1 reports

Quest Pharmatech 10-million-unit private placement

Shares: $ 10 million Price: $ 10 cents Warrants: $ 10 million share purchase warrants to purchase 10 million shares Exercise price: $ 15 cents for a period of two years Placees: $ two Insiders: $ AD Biotech Co. Ltd. (Hong-Gul Cheong) seven million; Hong-Gul ... [Published Stockwatch - Jan 23 2014]

Quotes

In February news reports said, "As many as one in four hundred women test positive for the BRCA-1 gene, often called the "breast cancer gene." Leading U S biotech stocks have had a massive bull run this year, although recently the sector has had a correction on concerns of valuations. However some of the smaller microcap stocks have not seen the same volatile trading patterns."
"This collaborative clinical study is indicative of our progression as a cancer immunotherapy company and our focused interest in capitalizing on the growing understanding of cancer immunology to enhance the clinical potential of our antibody products. We look forward to working with Oncovir in the conduct of this important clinical trial combining Hiltonol® with Oregovomab" , said Dr. Madi R Madiyalakan, Quest's Chief Executive Officer
...Quest also holds numerous patents for the use of tumor associated monoclonal antibodies as immune modulators. "Both IgG and IgE technologies are complementary and provide a novel approach for enhancing the effectiveness of chemotherapy while activating specific immunity to fight the cancer" commented Dr. Madi R Madiyalakan , CEO of the Company
Quest chief executive officer Madi Madiyalakan said: "We look forward to working with Oncovir in the conduct of this important clinical trial combining Hiltonol with Oregovomab."

More Content

All (7) | News (6) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
TSX Biotech Stocks to Watch; Innovative Ovarian... [Published InvestorIdeas.com - Mar 26 2014]
(TSX.V: QPT) (TSX:ONC; NASDAQ:ONCY) (TSX.V:IMV)... [Published Live-PR.com - Mar 26 2014]
Quest PharmaTech Announces Third Combinatorial ... [Published Alberta Venture - Mar 19 2014]
Oncothyreon Reports Full Year and Fourth Quarte... [Published Barchart - Mar 13 2014]
Quest and Oncovir to evaluate combinatorial imm... [Published Pharmaceutical Technology - Jan 31 2014]
Quest Pharmatech, Oncovir to combine tech for s... [Published Stockwatch - Jan 29 2014]
Quest Pharmatech 10-million-unit private placement [Published Stockwatch - Jan 23 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.